DanCann Pharma A/S issues warrants to the executive management team
COPENHAGEN, Denmark, 06 April 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby today announces that the Board of Directors has issued 1,017,147 warrants to the executive management team in DanCann Pharma with a subscription rate of DKK 3.3327.The Board of Directors has decided to issue 1,017,147 warrants to the executive management team. The warrants program is dedicated for allocation to Company’s executive management team, whereby they have the opportunity of participating in a value growth in the Company’s shares. This is expected to lead to an